Solid-state battery business advanced with flat revenue at £1.1M, first Stereax sales, and increased EBITDA loss due to scaling Goliath prototypes. Early commercialization in defense and e-bikes, strong grant support, and a recent cash raise position the company for growth.Based on Ilika plc [IKA…
Key milestones achieved in Stereax and Goliath product lines, with initial commercial revenues and strong grant funding. EBITDA loss widened to £6.2m, but cash resources and new share placing support ongoing growth and commercialisation.Original document: Ilika plc [IKA] Slides Release — Jul. 29 20…
Commercialisation advanced for both Stereax and Goliath battery lines, with Stereax generating initial revenues and Goliath 10Ah prototypes validated for defence and e-bike use. Losses widened due to higher R&D and production costs, but a £5m equity raise post-period strengthens the balance sheet.O…
RNS Number : 9254L Ilika plc 10 July 2026 TR-1: Standard form for notification of major holdingsThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom…
RNS Number : 3978L Ilika plc 07 July 2026 THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN ARE RESTRICTED AND ARE NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, NEW ZEALAND, THE REPUBLI…
